BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/14/2026 8:39:30 AM | Browse: 50 | Download: 224
 |
Received |
|
2025-09-11 07:43 |
|
Peer-Review Started |
|
2025-09-11 07:43 |
|
First Decision by Editorial Office Director |
|
2025-09-17 08:31 |
|
Return for Revision |
|
2025-09-17 08:31 |
|
Revised |
|
2025-09-30 22:13 |
|
Publication Fee Transferred |
|
2025-10-07 16:36 |
|
Second Decision by Editor |
|
2025-12-02 02:46 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-03 04:07 |
|
Articles in Press |
|
2025-12-03 04:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-07 07:30 |
|
Publish the Manuscript Online |
|
2026-01-14 08:39 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Retrospective Study |
| Article Title |
Preformed vs de novo anti-human leukocyte antigens-DQ antibodies in kidney transplantation: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Oumaima Guissouss, Khalid Achiaou, Joumana El Turk, Asmaa Mourachid, Abdelhadi Cheggali, Ghislaine Medkouri, Benyounes Ramdani, Mohammed Benghanem Gharbi, Majda Taoudi Benchekroun and Siham Bennani |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Science and Technology Research Center (Morocco) “PhD-Associate Scholarship - PASS” Program |
88UH2C2023 |
|
| Corresponding Author |
Oumaima Guissouss, Faculty of Sciences Ain Chock, Laboratory of Integrative Biology, University Hassan II, El Jadida Road, Casablanca 20100, Morocco. oumaima.guissouss-etu@etu.univh2c.ma / oumayma.guissouss1@gmail.com |
| Key Words |
Kidney transplantation; Donor-specific antibodies; De novo donor-specific antibodie; Human leukocyte antigens DQ; Antibody-mediated rejection; Banff classification; Morocco |
| Core Tip |
This retrospective study highlights the emerging role of donor-specific anti- human leukocyte antigen (HLA)-DQ antibodies in kidney transplantation, an area where evidence from Moroccan populations remains scarce. Individual cases illustrate the clinical spectrum, but the findings derive from a systematic retrospective analysis. The study highlights the association between anti-HLA-DQ antibodies, antibody-mediated rejection, and graft outcomes, underscoring the need to integrate HLA-DQ monitoring into routine post-transplant follow-up and offering a valuable perspective for improving patient management in resource-limited settings. |
| Publish Date |
2026-01-14 08:39 |
| Citation |
Guissouss O, Achiaou K, El Turk J, Mourachid A, Cheggali A, Medkouri G, Ramdani B, Benghanem Gharbi M, Taoudi Benchekroun M, Bennani S. Preformed vs de novo anti-human leukocyte antigens-DQ antibodies in kidney transplantation: A retrospective study. World J Transplant 2026; 16(1): 114044 |
| URL |
https://www.wjgnet.com/2220-3230/full/v16/i1/114044.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v16.i1.114044 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
